United StatesResearchers at MIT are developing a portable diagnostic tool called PlasmoSniff, which uses nanoparticles to detect biomarkers in human breath that indicate diseases such as pneumonia. The process involves a person inhaling specially designed nanoparticles that bind to disease-specific biomarkers. These biomarkers are released and exhaled if certain enzymes present during infections are detected. The technology was initially tested on mice in 2020, but recent advancements allow for detection using enhanced Raman spectroscopy, making it feasible for use in clinical or home settings. The device could provide results in under 10 minutes and has potential applications beyond medical diagnostics, including detecting industrial chemicals or airborne pollutants.
Bias read (Center): The article discusses a scientific development with no direct political implications. It focuses on technological innovation in healthcare and does not involve political figures, policies, or contentious issues.
